Mortality Risk Following Application of a Paclitaxel-Coated Stent in Femoropopliteal Lesions.

Tomonori KatsukiMitsuyoshi TakaharaYoshimitsu SogaShin OkamotoOsamu Iida Masahiko FujiharaDaizo KawasakiKenji Ando

Published in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2019)

Mortality risk following application of a PTX-coated stent did not increase over 5 years, irrespective of the dose. A PTX-coated stent for femoropopliteal lesions in PAD patients is a safe treatment option.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
peripheral artery disease
smoking cessation
replacement therapy